Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SPTSSA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
DPY30 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
FGFR1OP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DYNLL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SSR3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAH - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UXS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HDAC2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC35C2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FBXO11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DNMT3A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ATP5C1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IL13RA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SVIP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NUCKS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SRSF10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LRRC37A2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HLTF - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GXYLT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EID1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on